Tony Cates joins Cycle Group Holdings Board of Directors Tony Cates joins Cycle Group Holdings Board of Directors News, Nityr Tony Cates joins Cycle Group Holdings Board of Directors By Kierah Bircham|2021-10-06T10:39:32+01:00October 6th, 2021|News, Nityr| Read More
Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE) Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE) News, Nityr Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE) By Kierah Bircham|2021-09-28T11:36:58+01:00September 28th, 2021|News, Nityr| Read More
Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients News, Nityr Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients By Kierah Bircham|2021-09-14T16:56:52+01:00September 10th, 2021|News, Nityr| Read More
Cycle Pharmaceuticals appoints Denise Moody as Chief Operating Officer Cycle Pharmaceuticals appoints Denise Moody as Chief Operating Officer Corporate, News Cycle Pharmaceuticals appoints Denise Moody as Chief Operating Officer By Kierah Bircham|2021-06-28T11:44:17+01:00June 28th, 2021|Corporate, News| Read More
Cycle Pharmaceuticals appoints Steve McCue as Chief Financial Officer Cycle Pharmaceuticals appoints Steve McCue as Chief Financial Officer Corporate, News Cycle Pharmaceuticals appoints Steve McCue as Chief Financial Officer By Kierah Bircham|2021-05-25T17:41:24+01:00May 25th, 2021|Corporate, News| Read More
Dr Alejandra Bruna joins Cycle Group Holdings Board of Directors Dr Alejandra Bruna joins Cycle Group Holdings Board of Directors News, Nityr Dr Alejandra Bruna joins Cycle Group Holdings Board of Directors By Kierah Bircham|2021-05-17T18:52:30+01:00April 29th, 2021|News, Nityr| Read More
NITYR (nitisinone) Tablets for Tyrosinaemia Type 1 receives Marketing Authorization in New Zealand NITYR (nitisinone) Tablets for Tyrosinaemia Type 1 receives Marketing Authorization in New Zealand News, Nityr NITYR (nitisinone) Tablets for Tyrosinaemia Type 1 receives Marketing Authorization in New Zealand By Kierah Bircham|2021-05-17T18:52:30+01:00March 15th, 2021|News, Nityr| Read More
Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department Generics, News Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department By Kierah Bircham|2021-05-17T18:52:30+01:00December 2nd, 2020|Generics, News| Read More
Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel News, Nityr Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel By Kierah Bircham|2021-05-17T18:52:30+01:00October 19th, 2020|News, Nityr| Read More
US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients Generics, News US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients By Kierah Bircham|2021-05-17T18:52:30+01:00September 14th, 2020|Generics, News| Read More
